New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...

MMI’s REMIND study will evaluate its Symani surgical robot in reestablishing lymphatic drainage pathways to treat Alzheimer’s ...

Ironically enough, his initial downfall had nothing to do with Daraprim. Soon after he became infamous, federal prosecutors ...

Cognition Therapeutics, Inc. ( ($CGTX) ) has released its Q3 earnings. Here is a breakdown of the information Cognition Therapeutics, Inc.

Only 200,000, or 3%, are diagnosed with Alzheimer's before age 65. Such an early onset means the disease is more likely to ...

November is Alzheimer’s Awareness Month, a time to spotlight the growing impact of the disease across the United States and ...

Axsome Therapeutics, Inc. remains a Sell due to an undifferentiated CNS pipeline, heavy SG&A and net losses. Learn more about ...

Bill Gates shares personal insights on Alzheimer’s and a new FDA-approved blood test that could revolutionize early diagnosis ...

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...

A recent study has revealed how adjusting the body’s internal rhythm might protect the brain from Alzheimer’s damage. The discovery opens the door to treatments that align the body’s clock with brain ...

First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s ...